Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DDB1 | Q16531 | 15/20 | 0.58 |
| ▸ | CRBN | Q96SW2 | 15/20 | 0.58 |
| ▸ | CACNA1G | O43497 | 2/20 | 0.45 |
| ▸ | CACNA1H | O95180 | 2/20 | 0.45 |
| ▸ | FABP4 | P15090 | 1/20 | 0.44 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.44 |
| ▸ | IKZF3 | Q9UKT9 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.41 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22512101 | 1.00 | DDB1 (0.58) | DDB1CRBNCACNA1GCACNA1HFABP4 | |
| SCHEMBL22511713 | 1.00 | DDB1 (0.58) | DDB1CRBNCACNA1GCACNA1HFABP4 | |
| SCHEMBL31586188 | 0.96 | DDB1 (0.60) | DDB1CRBNCACNA1GCACNA1HFABP4 | |
| SCHEMBL21759508 | 0.85 | CRBN (0.64) | DDB1CRBNIKZF3ALDH1A1CHRM2 | |
| SCHEMBL28649449 | 0.85 | DDB1 (0.53) | DDB1CRBNCACNA1GCACNA1HALDH1A1 | |
| SCHEMBL24269178 | 0.83 | DDB1 (0.51) | DDB1CRBNCACNA1GCACNA1HOPRM1 | |
| SCHEMBL29402993 | 0.83 | DDB1 (0.51) | DDB1CRBNCACNA1GCACNA1HOPRM1 | |
| SCHEMBL21759498 | 0.83 | CRBN (0.67) | DDB1CRBNIKZF3ALDH1A1CHRM2 | |
| SCHEMBL22776829 | 0.83 | CRBN (0.58) | DDB1CRBNCACNA1GCACNA1HIKZF3 | |
| SCHEMBL25122924 | 0.82 | DDB1 (0.48) | DDB1CRBNCACNA1GCACNA1HIKZF3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025103502-A1 | COMPOUNDS AND METHODS OF TREATING CANCERS | CULLGEN INC. (US) | 2025-05-22 | — | — | WO | disclosed |